Bradley Foster & Sargent Inc. CT Has $1.56 Million Stock Position in Church & Dwight Co., Inc. (NYSE:CHD)

Bradley Foster & Sargent Inc. CT reduced its position in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 4.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 15,048 shares of the company’s stock after selling 750 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Church & Dwight were worth $1,560,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in CHD. Norges Bank acquired a new position in Church & Dwight during the 4th quarter worth approximately $259,967,000. Capital International Investors raised its stake in shares of Church & Dwight by 39.2% in the fourth quarter. Capital International Investors now owns 9,004,713 shares of the company’s stock worth $851,414,000 after purchasing an additional 2,533,877 shares during the last quarter. Capital Research Global Investors purchased a new stake in shares of Church & Dwight in the first quarter worth approximately $69,384,000. Vanguard Group Inc. raised its stake in shares of Church & Dwight by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 30,265,072 shares of the company’s stock worth $2,861,865,000 after purchasing an additional 354,946 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in shares of Church & Dwight by 26.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,334,950 shares of the company’s stock worth $126,233,000 after purchasing an additional 277,017 shares during the last quarter. 86.60% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently commented on CHD. TD Cowen began coverage on Church & Dwight in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $116.00 price objective for the company. Stifel Nicolaus lowered their price objective on Church & Dwight from $107.00 to $105.00 and set a “hold” rating for the company in a research note on Monday, August 5th. Barclays increased their price objective on Church & Dwight from $80.00 to $82.00 and gave the stock an “underweight” rating in a research note on Tuesday, August 6th. Evercore ISI reduced their target price on Church & Dwight from $110.00 to $101.00 and set an “in-line” rating for the company in a report on Monday, August 5th. Finally, Morgan Stanley lowered Church & Dwight from an “overweight” rating to an “equal weight” rating and set a $110.00 target price for the company. in a report on Monday, September 9th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $106.58.

Insiders Place Their Bets

In other Church & Dwight news, EVP Barry A. Bruno sold 59,328 shares of the stock in a transaction on Monday, August 5th. The stock was sold at an average price of $99.37, for a total transaction of $5,895,423.36. Following the sale, the executive vice president now owns 4,319 shares in the company, valued at $429,179.03. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 2.00% of the company’s stock.

Church & Dwight Price Performance

Shares of NYSE CHD opened at $102.61 on Thursday. The stock has a fifty day simple moving average of $102.06 and a two-hundred day simple moving average of $104.21. Church & Dwight Co., Inc. has a 1-year low of $82.25 and a 1-year high of $110.31. The firm has a market cap of $25.12 billion, a price-to-earnings ratio of 32.57, a price-to-earnings-growth ratio of 3.55 and a beta of 0.54. The company has a current ratio of 1.53, a quick ratio of 0.98 and a debt-to-equity ratio of 0.51.

Church & Dwight (NYSE:CHD) last announced its quarterly earnings data on Friday, August 2nd. The company reported $0.93 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.09. Church & Dwight had a return on equity of 19.86% and a net margin of 13.38%. The business had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.51 billion. During the same period in the prior year, the company earned $0.92 earnings per share. Church & Dwight’s revenue was up 3.9% compared to the same quarter last year. Analysts anticipate that Church & Dwight Co., Inc. will post 3.43 earnings per share for the current year.

Church & Dwight Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 3rd. Shareholders of record on Thursday, August 15th were given a dividend of $0.2838 per share. The ex-dividend date was Thursday, August 15th. This represents a $1.14 annualized dividend and a dividend yield of 1.11%. Church & Dwight’s dividend payout ratio is currently 35.87%.

Church & Dwight Profile

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.